Editas Medicine, Inc.·4

Feb 9, 4:30 PM ET

Eaton Bruce 4

4 · Editas Medicine, Inc. · Filed Feb 9, 2023

Insider Transaction Report

Form 4
Period: 2023-02-07
Eaton Bruce
EVP, Chief Business Officer
Transactions
  • Sale

    Common Stock

    2023-02-07$11.10/sh346$3,84164,290 total
Footnotes (1)
  • [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 6, 2023. The sale does not represent a discretionary trade by the Reporting Person.

Documents

1 file
  • 4
    form4-02092023_040202.xmlPrimary